Policy & Medicine – Page 2 – Legal, Regulatory, and Compliance Issues

Inspiring Integrity: How to Win with Compliance and Propel Performance

Trump Administration’s Consideration of DTC Ban and Implications for Medical Communications

Senate Releases Report Alleging MA Insurers Deny Patient Care to Increase Profits

Hospital Price Transparency Compliance Drops 38%

OPDP Sends Untitled Letter to Merz Over Social Media Post

Stakeholders Provide Feedback on FDA Misinformation Draft Guidance

Steward Health CEO Held in Contempt of Congress for Refusal to Testify

This Week in Policy and Medicine Podcast: December 6, 2024

Navigating Change: SAMHSA’s New Federal Guidelines for Opioid Treatment Programs

FDA Issues Reports on Communication and Guidance Document Best Practices

Fifth Circuit Affirms Lower Court’s Decision to Vacate Certain Guidance Under the No Surprises Act

Bipartisan Legislation Introduced to Avoid Decreased Medicare Reimbursement Rates

Minnesota’s 340B Program Report Sheds Light on Potential Abuses and Sparks Call for Reforms